Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Potential new treatment for Huntington and Parkinson patients ...

08.03.2006


... can inclusions bodies be good news for neurodegenerative diseases?



A potential new treatment for neurodegenerative disorders, which seems to be able to reduce the toxic protein aggregates characteristic of many of these diseases, is published online this week in the journal Proceedings of the National Academy of Sciences. Since it is believed that in most neurodegenerative disorders, like Parkinson and Huntington’s disease (PD and HD respectively), abnormal protein aggregates are major culprits associated with neurodegeneration, this research may have important implications for the lives of thousands of neurodegenerative patients all over the world.

Parkinson’s and Huntington’s diseases are incurable devastating brain disorders that result from the death of brain cells associated with muscle control. Both illnesses, like many other neurodegenerative diseases, result from the formation of misshaped/incorrectly folded versions of normal proteins (all proteins have a specific shape/folding associated with their normal function) that tend to clump together leading to the death of the cells in the neighbourhood.


But the formation of these abnormal proteins is usually not a problem as two effective mechanisms exist to eliminate them: proteasomes, which are multi-protein complexes capable of digesting/cutting the toxic proteins into small pieces to be easily disposed and molecular chaperones, proteins capable of assisting other proteins to “move” into their correct shape/fold. In the cases where abnormal proteins are allowed to accumulate, as it happens in many neurodegenerative diseases, it is believed that these protective systems are malfunctioning. The fact that HD patients are known to have problems with faulty proteasomes supports this hypothesis.

Furthermore, cells with high accumulation of misshaped proteins, including those from PD and HD patients, can also present a cellular structure called inclusion body, which is known to accumulate high quantities of the altered aggregated protein. The role of these inclusions is not clear, and while for a long time they were believed to be toxic and part of the disease process, in recent years, this has been challenged and some researchers now believe that inclusion bodies (also called inclusions) might have a role eliminating the aggregates of toxic proteins. The fact that inclusion bodies are known to contain high quantities of proteasomes further supports this hypothesis. Nevertheless, research in therapies for neurodegenerative diseases seems to continue orientated towards drugs capable of diminish these cellular structures

But Ruth A. Bodner, Tiago Fleming Outeiro, a Portuguese scientist, Aleksey G. Kazantsev and colleagues from the Center for Cancer Research, Massachusetts Institute of Technology, Cambridge and the Mass General Institute for Neurodegenerative Disease, Massachusetts General Hospital, and Harvard Medical School, US had a different idea.

In fact, although much research has been done on compounds capable of diminish the number of inclusions in cells with neurodegenerative mechanisms so far the results have been inconclusive. This observation, together with the emerging believe that inclusions might actually be involved in cells’ protection, made Bodner, Outeiro, Kazantsev and colleagues decide to look instead at substances known to increase the number of inclusions, analysing their effect on neurodegenerative mechanisms. For that they used cellular models of PD and HD consisting of cells, growing in laboratory, which are induced to produce toxic quantities of the protein associated with each of the diseases.

As expected, Bodner, Outeiro, Kazantsev and colleagues found that the compounds that increased the amount of misshaped protein also induced the formation of cellular inclusions. But, more interestingly, was the fact that among those substances that increased inclusions’ numbers, a few were able to revert (and very efficiently) some of the harmful effects induced by the toxic aggregates of misshaped proteins.

In fact, in the cellular model of HD some of the tested substances were able to recover proteasome function - which is crucial to eliminate abnormal proteins in the cells and is known to be defective in HD – while in the PD model the tested substances were capable of diminish the toxicity of the misshaped proteins associated with disease and, in consequence, also cellular death. Furthermore, these beneficial effects correlated directly with the number of inclusions formed, further supporting the idea that inclusions bodies are not necessarily part of the disease, but instead a coing mechanism.

Bodner, Outeiro, Kazantsev and colleagues also had two other very interesting findings. Firstly, the remarkable effectiveness of the substances tested - the most effective compound was able to recover up to 39% of proteasome function in the HD model, while reducing 46% the toxicity associated with the protein aggregates in the model of PD – what raises hopes that these substances might become important new drugs. Secondly, the identification of specific atoms in the tested substances, that, when changed, reduced drastically the substances’ effectiveness. This last observation raises the possibility that different changes in the already identified areas, might, instead, be able to increase even more the effectiveness of the potential drugs.

At the moment the treatments available for neurodegenerative patients are only able to treat the individual symptoms but not the disease. What Bodner, Outeiro, Kazantsev and colleagues’ research might mean is that one day we will be able to delay, or even revert, disease symptoms, giving patients the possibility of enjoying for longer the pleasure of a normal life. Although much more research is necessary in order to confirm these results, Bodner, Outeiro, Kazantsev and colleagues’ new work is undoubtedly exciting news for neurodegenerative patients all over the world.

Piece researched and written by: Catarina Amorim ( catarina.amorim@linacre.ox.ac.uk)

Catarina Amorim | alfa
Further information:
http://www.pnas.org/cgi/content/abstract/0511256103v1

More articles from Life Sciences:

nachricht Topologische Quantenchemie
21.07.2017 | Max-Planck-Institut für Chemische Physik fester Stoffe

nachricht Topological Quantum Chemistry
21.07.2017 | Max-Planck-Institut für Chemische Physik fester Stoffe

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Manipulating Electron Spins Without Loss of Information

Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.

For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...

Im Focus: The proton precisely weighted

What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.

To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...

Im Focus: On the way to a biological alternative

A bacterial enzyme enables reactions that open up alternatives to key industrial chemical processes

The research team of Prof. Dr. Oliver Einsle at the University of Freiburg's Institute of Biochemistry has long been exploring the functioning of nitrogenase....

Im Focus: The 1 trillion tonne iceberg

Larsen C Ice Shelf rift finally breaks through

A one trillion tonne iceberg - one of the biggest ever recorded -- has calved away from the Larsen C Ice Shelf in Antarctica, after a rift in the ice,...

Im Focus: Laser-cooled ions contribute to better understanding of friction

Physics supports biology: Researchers from PTB have developed a model system to investigate friction phenomena with atomic precision

Friction: what you want from car brakes, otherwise rather a nuisance. In any case, it is useful to know as precisely as possible how friction phenomena arise –...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Closing the Sustainability Circle: Protection of Food with Biobased Materials

21.07.2017 | Event News

»We are bringing Additive Manufacturing to SMEs«

19.07.2017 | Event News

The technology with a feel for feelings

12.07.2017 | Event News

 
Latest News

NASA looks to solar eclipse to help understand Earth's energy system

21.07.2017 | Earth Sciences

Stanford researchers develop a new type of soft, growing robot

21.07.2017 | Power and Electrical Engineering

Vortex photons from electrons in circular motion

21.07.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>